UBS Group
AARD

UBS Group’s Aardvark Therapeutics, Inc. Common Stock AARD Stock Holding History

UBS Group’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$702K Buy
51,924
+37,219
+253% +$503K ﹤0.01% 4603
2025
Q1 		$110K Buy
+14,705
New +$110K ﹤0.01% 5712